Figure S4
1
Figure S4 JURKAT + imatinib JURL-MK1 + dasatinib -11 -10 -9 -8 -7 -6 -5 -4 0 50 100 log[dasatinib](M ) M FI (% ofcontrol) JURL-MK1 + imatinib -8 -7 -6 -5 -4 0 50 100 log[im atinib](M ) M FI (% ofcontrol) MOLM-7 + dasatinib -11 -10 -9 -8 -7 -6 -5 -4 0 50 100 log[dasatinib](M ) M FI (% ofcontrol) MOLM-7 + imatinib -8 -7 -6 -5 -4 0 50 100 log[im atinib](M ) M FI (% ofcontrol) HEL + imatinib -8 -7 -6 -5 -4 0 50 100 log[im atinib](M ) M FI (% ofcontrol) -8 -7 -6 -5 -4 0 50 100 150 log[im atinib](M ) M FI (% ofcontrol)
-
Upload
regan-conway -
Category
Documents
-
view
21 -
download
0
description
JURL-MK1 + dasatinib. JURL-MK1 + imatinib. MOLM-7 + dasatinib. MOLM-7 + imatinib. JURKAT + imatinib. HEL + imatinib. Figure S4. - PowerPoint PPT Presentation
Transcript of Figure S4
Figure S4
JURKAT + imatinib
JURL-MK1 + dasatinib
-11 -10 -9 -8 -7 -6 -5 -40
50
100
log[dasatinib] (M)
MFI
(% o
f co
ntr
ol)
JURL-MK1 + imatinib
-8 -7 -6 -5 -40
50
100
log[imatinib] (M)
MFI
(% o
f co
ntr
ol)
MOLM-7 + dasatinib
-11 -10 -9 -8 -7 -6 -5 -40
50
100
log[dasatinib] (M)
MFI
(% o
f co
ntr
ol)
MOLM-7 + imatinib
-8 -7 -6 -5 -40
50
100
log[imatinib] (M)
MFI
(% o
f co
ntr
ol)
HEL + imatinib
-8 -7 -6 -5 -40
50
100
log[imatinib] (M)
MFI
(% o
f co
ntr
ol)
-8 -7 -6 -5 -40
50
100
150
log[imatinib] (M)
MFI
(% o
f co
ntr
ol)